James P Shaffer - Net Worth and Insider Trading
James P Shaffer Net Worth
The estimated net worth of James P Shaffer is at least $1 Million dollars as of 2024-04-23. James P Shaffer is the VP & Chief Commercial Officer of Halozyme Therapeutics Inc and owns about 26,300 shares of Halozyme Therapeutics Inc (HALO) stock worth over $1 Million. James P Shaffer is also the Chief Business Officer of Eiger BioPharmaceuticals Inc and owns about 187 shares of Eiger BioPharmaceuticals Inc (EIGRQ) stock worth over $635. Details can be seen in James P Shaffer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James P Shaffer has not made any transactions after 2016-08-18 and currently still holds the listed stock(s).
Transaction Summary of James P Shaffer
James P Shaffer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James P Shaffer owns 2 companies in total, including Eiger BioPharmaceuticals Inc (EIGRQ) , and Halozyme Therapeutics Inc (HALO) .
Click here to see the complete history of James P Shaffer’s form 4 insider trades.
Insider Ownership Summary of James P Shaffer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EIGRQ | Eiger BioPharmaceuticals Inc | 2016-08-18 | Chief Business Officer |
| HALO | Halozyme Therapeutics Inc | 2014-02-02 | VP & Chief Commercial Officer |
James P Shaffer Latest Holdings Summary
James P Shaffer currently owns a total of 2 stocks. Among these stocks, James P Shaffer owns 26,300 shares of Halozyme Therapeutics Inc (HALO) as of November 14, 2012, with a value of $1 Million and a weighting of 99.94%. James P Shaffer also owns 187 shares of Eiger BioPharmaceuticals Inc (EIGRQ) as of August 18, 2016, with a value of $635 and a weighting of 0.06%.
Latest Holdings of James P Shaffer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HALO | Halozyme Therapeutics Inc | 2012-11-14 | 26,300 | 39.27 | 1,032,801 |
| EIGRQ | Eiger BioPharmaceuticals Inc | 2016-08-18 | 187 | 3.40 | 635 |
Holding Weightings of James P Shaffer
James P Shaffer Form 4 Trading Tracker
According to the SEC Form 4 filings, James P Shaffer has made a total of 0 transactions in Halozyme Therapeutics Inc (HALO) over the past 5 years. The most-recent trade in Halozyme Therapeutics Inc is the acquisition of 20,000 shares on November 14, 2012, which cost James P Shaffer around $104,400.
According to the SEC Form 4 filings, James P Shaffer has made a total of 0 transactions in Eiger BioPharmaceuticals Inc (EIGRQ) over the past 5 years. The most-recent trade in Eiger BioPharmaceuticals Inc is the acquisition of 104 shares on August 18, 2016, which cost James P Shaffer around $49,063.
Insider Trading History of James P Shaffer
- 1
James P Shaffer Trading Performance
GuruFocus tracks the stock performance after each of James P Shaffer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James P Shaffer is -12.12%. GuruFocus also compares James P Shaffer's trading performance to market benchmark return within the same time period. The performance of stocks bought by James P Shaffer within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James P Shaffer's insider trading performs compared to the benchmark.
Performance of James P Shaffer
Average Return
-5.59%
Outperforming Transactions
25%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.83 | -12.12 | -19.04 | -5.59 | -3.92 | -1.71 |
| Relative Return to S&P 500(%) | -5.04 | -17.4 | -30.59 | -24.96 | -20.9 | -13.45 |
James P Shaffer Ownership Network
Ownership Network List of James P Shaffer
Ownership Network Relation of James P Shaffer
James P Shaffer Owned Company Details
What does Eiger BioPharmaceuticals Inc do?
Who are the key executives at Eiger BioPharmaceuticals Inc?
James P Shaffer is the Chief Business Officer of Eiger BioPharmaceuticals Inc. Other key executives at Eiger BioPharmaceuticals Inc include 10 percent owner Richard A Kayne , 10 percent owner Leen Kawas , and Chief Business Officer Ingrid Choong .
Eiger BioPharmaceuticals Inc (EIGRQ) Insider Trades Summary
Over the past 18 months, James P Shaffer made no insider transaction in Eiger BioPharmaceuticals Inc (EIGRQ). Other recent insider transactions involving Eiger BioPharmaceuticals Inc (EIGRQ) include a net purchase of 27,500 shares made by Thomas John Dietz , a net purchase of 278,239 shares made by Richard A Kayne , and a net purchase of 100,000 shares made by Jeffrey S Glenn .
In summary, during the past 3 months, insiders sold 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 896 shares of Eiger BioPharmaceuticals Inc (EIGRQ) were sold and 15,086 shares were bought by its insiders, resulting in a net purchase of 14,189 shares.
Eiger BioPharmaceuticals Inc (EIGRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eiger BioPharmaceuticals Inc Insider Transactions
James P Shaffer Mailing Address
Above is the net worth, insider trading, and ownership report for James P Shaffer. You might contact James P Shaffer via mailing address: 12916 Anglewood Ct., Raleigh Nc 27614.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
